According to the latest report by IMARC Group,the global allergy immunotherapies market reached a value of US$ 2.56 Billion in 2021.Allergy immunotherapy is a long-term medical treatment that aims to desensitize the immune system of an individual against specific allergens that trigger allergy symptoms. This therapy involves regular administration of gradually increasing doses of allergens in the patient’s body to improve the response of the immune system.

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Allergy
Immunotherapies
Market Research Report
and Forecast 2022-2027
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Allergy Immunotherapies Market Outlook 2027:
According to the latest report by IMARC Group, titled "Allergy Immunotherapies Market: Global
Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global allergy
immunotherapies market reached a value of US$ 2.56 Billion in 2021.
Allergy immunotherapy is a long-term medical treatment that aims to desensitize the immune system
of an individual against specific allergens that trigger allergy symptoms. This therapy involves regular
administration of gradually increasing doses of allergens in the patient’s body to improve the response
of the immune system. This can often lead to long-lasting relief of the allergy symptoms following
treatment discontinuation, thereby offering a long-term impact.
Apart from this, immunotherapy is also associated with reducing inflammation, improving
immunological tolerance and enhancing the quality of the patient’s life. Consequently, it is widely used
as a preferred method for treating allergic asthma, allergic rhinitis, peanuts allergy, cat allergy,
conjunctivitis and other kinds of hypersensitivity.
Request for a free sample: https://www.imarcgroup.com/allergy-immunotherapies-
market/requestsample

4. Report Description
Report Description and Highlights
Global Allergy Immunotherapies Market Trends:
The global market is primarily driven by the increasing prevalence of allergies that are being triggered
by numerous lifestyle changes and environmental factors. A significant increase in the global pollution
levels and the increasing numbers of active and passive smokers have contributed to a decline in the
functioning of the human immunity system.
Consequently, allergy immunotherapy is widely being used to alter the course of the allergy with
persistent effects. Along with this, there has been a considerable growth in the healthcare budgets of
various countries, which is creating a positive outlook for the market. This is being supported by the
favorable initiatives undertaken by the governments of numerous countries to spread awareness
regarding the high efficacy rates of the therapy.
The market is further driven by constant advancements in drug development technologies. Several
companies have developed targeted drugs for allergies in the form of allergen immunotherapy tablets
(AITs) and Sublingual immunotherapy (SLIT) tablets which are gaining widespread prominence among
the users. Some of the other factors, such as advancements in the field of allergy diagnostics and
inflating per capita income levels, are also influencing the market growth.

5. Market Summary:
Breakup by Treatment Type:
• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)
Breakup by Allergy Type:
• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
Breakup by Distribution Channel:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Report Description
Report Description and Highlights

6. Breakup by Region:
• North America
• Asia Pacific
• Europe
• Middle East and Africa
• Latin America
Looking forward, IMARC Group expects the market to reach US$ 4.63 Billion by 2027, exhibiting at a
CAGR of 10.2% during 2022-2027.
Report Description
Report Description and Highlights

7. Competitive Landscape With Key players:
• BALK-Abello A/S
• Allergy Therapeutics
• Stallergenes Greer
• HAL Allergy Group
• DBV Technologies
• Merck Group
• Aimmune Therapeutics
• Circassia Pharmaceuticals
• Anergis SA
• Biomay AG
View Report TOC, Figures and Tables: https://www.imarcgroup.com/allergy-immunotherapies-market
Report Description
Report Description and Highlights

8. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

11. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us